Market Tracker

09/29 5:16pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.2145
Delayed Data
As of 4:01pm ET
 -0.0056 / -2.54%
Today’s Change
0.20
Today|||52-Week Range
0.54
-40.91%
Year-to-Date

Today’s Trading

Previous close0.22
Today’s open0.22
Day’s range0.21 - 0.22
Volume984,018
Average volume (3 months)686,020
Market cap$52.2M
Dividend yield--
Data as of 4:01pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)+27.27%
Earnings growth (this year)+12.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.31

Competitors

 Today’s
change
Today’s
% change
MRNSMarinus Pharmaceutic...-0.73-26.74%
PTNPalatin Technologies...-0.01-1.69%
RPRXRepros Therapeutics ...+0.02+0.96%
IPCIIntellipharmaceutics...-0.03-1.48%
Data as of 4:02pm ET, 09/29/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts